Inspur Information Next-Generation G7 Server Platform Offers Power and Flexibility with Support for AMD EPYC™ 9004 Series Processors
The platform achieves an 86% performance improvement, providing a greener solution with liquid cooling technology….
ISP
Cellectis Publishes Manuscript in Frontiers Bioengineering and Biotechnology Unveiling Efficient Multitool/Multiplex Gene Engineering combining TALEN® and TALE Base Editors (TALE-BE)
NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS –…
Valneva Reports Nine-Month 2022 Results and Provides Corporate Updates
Total nine-month revenues of €249.9 million, a ~ 3.5-fold increase compared to 2021 Product sales…
Formal Opening of DE-CIX Richmond Internet Exchange – Bringing World-Class Connectivity Solutions to Henrico County
Formal opening ceremony attended by “Father of the Internet” Vint Cerf and Secretary of Administration…
Nkarta Presents Data Supporting Engineered NK Cell Based Combination Therapies and Next Generation Commercial-Scale Manufacturing Platform at SITC 37th Annual Meeting
Improved Anti-Tumor Activity Demonstrated by the Combination of NKX019 and a CD20-directed Monoclonal Antibody in…
Intellia Presents Updated Interim Data from the Cardiomyopathy Arm of Ongoing Phase 1 Study of NTLA-2001, an Investigational CRISPR Therapy for the Treatment of Transthyretin (ATTR) Amyloidosis at the American Heart Association Scientific Sessions 2022
Data presented in late-breaking oral presentation demonstrated deep and consistent TTR reduction following a single…
Ubiquiti Inc. Reports First Quarter Fiscal 2023 Financial Results
~ Revenues of $498.1 million ~ ~ GAAP Diluted Earnings Per Share of $1.54 ~…
Cimeio Therapeutics Announces Acceptance of ASH Abstracts Detailing Pipeline
–Company also strengthens Board of Directors with appointments of Luca Santarelli and Michael Tomsicek– BASEL,…
CRISPR Therapeutics Announces Poster Presentation on CTX110® at the American Society of Hematology (ASH) 2022 Annual Meeting
ZUG, Switzerland and BOSTON, Nov. 03, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a…
CRISPR Therapeutics Announces Planned Transition of Chief Operating Officer
ZUG, Switzerland and BOSTON, Oct. 27, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a…
Intellia Therapeutics to Hold Conference Call to Discuss Third Quarter 2022 Earnings and Company Updates
CAMBRIDGE, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage…
iSpecimen Launches New Open Feasibilities Dashboard on the iSpecimen Marketplace Platform to Enhance Biospecimen Fulfillment for Global Partner Network
New Feature Provides Suppliers with Research Transparency to Optimize Fulfillment Process LEXINGTON, Mass., Oct. 27,…
TransCode Therapeutics Reports Positive Preclinical Results with its Lead Candidate, TTX-MC138, in Pancreatic Adenocarcinoma
Study provides additional support for further evaluation of TransCode’s lead therapeutic candidate, TTX-MC138, in clinical…
DE-CIX and FirstLight Partner to Offer Transport to Peering at DE-CIX New York
Access to DE-CIX New York now available from over 13,000 lit locations across FirstLight’s robust…
Excision BioTherapeutics to Host Key Opinion Leader Webinar on HIV and the Ongoing Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure
Webinar will focus on the unmet medical need in HIV, therapeutic applications of gene delivery…
Excision BioTherapeutics to Host Key Opinion Leader Webinar on HIV and the Ongoing Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure
Webinar will focus on the unmet medical need in HIV, therapeutic applications of gene delivery…
Telesis Bio and Cellibre Announce Collaboration to Optimize Development of Future BioXp® DBC instrument
Agreement will allow researchers to streamline development of on-demand and automated production of CRISPR-Cas9 guide…
Editas Medicine Presents Preclinical Data on EDIT-103 for Rhodopsin-associated Autosomal Dominant Retinitis Pigmentosa at the European Society of Gene and Cell Therapy Annual Meeting
Studies in non-human primates demonstrated nearly 100% gene editing and knockout of endogenous RHO gene…
Vor Bio Demonstrates Potential of Base and Sequential Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment
-Multiplex deletion of myeloid antigens CD33 and CLL-1 or CD33 and CD123 in human hematopoietic…
Virgin Orbit Announces ‘Start Me Up’ Mission as Flight Hardware Takes off for Spaceport Cornwall Launch Debut
Manifest complete, flight hardware departs California for the first orbital launch from U.K. soil LONG…